Skip over main navigation
  • Log in
  • Basket: (0 items)
Solving Kids' Cancer
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
Shop Contact us Donate
Menu
  • About Neuroblastoma
    • About Neuroblastoma Home
    • What is neuroblastoma?
    • Symptoms
    • Diagnosis
    • Risk Groups and Staging
    • Clinical Trials
    • Treatment for Neuroblastoma
  • Find Support
    • Family support
    • Access treatment
    • Neuroblastoma Parent Education Conference
      • Neuroblastoma Parent Global Symposium 2021
      • See past conferences
    • Other sources of help
  • Research
    • Our research
    • Scientific Advisory Board
    • Research Funding
      • Funding award process
      • Grant Award Calls
    • Projects
    • Funding partners
    • Research policies
    • Research blog
  • Get Involved
    • Help Us Today
    • Shop
    • Ambassador Programme
    • Corporate partnerships
    • Challenge events
    • Set up a fundraising page
    • Gaming
    • Fundraising resources
  • Children’s stories
    • Stories
    • Children’s campaigns
    • In memory
    • Named funds
  • About us
    • What we do
    • Meet the team
      • Trustees
      • Our team
    • Patrons
    • Parent Involvement Forum
    • Join our Team
    • Annual reports
  • News
    • News
    • Blogs
  • Admin
    • Log in
  • Basket: (0 items)
  1. About Neuroblastoma
  2. About Neuroblastoma Home

Clinical Trials

Clinical trials are research studies involving patients, that aim to find out if a new treatment is safe and effective. As well as the benefit of bringing new treatments into the clinic for mainstream use, clinical trials may offer the chance to access therapies which are outside of standard care. For certain neuroblastoma patients whose disease is advanced or does not respond well to standard treatment- enrolling onto a clinical trial can be an added option to overcome their illness. 

How do clinical trials work? 

Clinical trials progress through four phases to bring a new treatment to market by testing effectiveness, suitable dosage and looking for side effects. 

Phase I: This is usually the first time the treatment has been trialled in people. It is usually tested on a small group of people; some may be healthy volunteers. The main aim of a Phase I trial is to test the safety of a medicine and look for any initial side effects. 

Phase II: Phase II trials involve larger groups of people who have the illness that is being targeted. At this stage, the aim is to find the appropriate dose of the treatment and find out whether it is effective against the targeted disease. In the case of neuroblastoma, researchers would most likely be looking at the tumour's response to the therapy. 

Phase III: Following successful Phase II trial, the treatment will be tested in a larger population of people with the disease of interest. It will often be tested against an existing treatment or a placebo to see if it is better in practice, and to monitor any side effects. If a treatment is successful in a Phase III trial, it will then move forward for approval into the clinic by the appropriate governing bodies. 

Phase IV: After a new treatment has been approved, the safety, effectiveness and side effects will continue to be monitored whilst it is being used in practice. This is not always necessary for every new treatment. 

  

Published: 7th June, 2019

Updated: 22nd March, 2022

Author: Deleted User

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Ronin's Spidey Hike

    Ronin's Spidey Hike

    Ronin is doing a 3 mile hike home from playgroup on the last day of term to raise money for his cousin Flora. He will be dressed up as Spiderman!
    Ronin loves walking and would like to help raise lots of money for Floras treatment in America

    Thankyou so much for any donations

  • Family Support Coordinator

    Solving Kids' Cancer is looking for a Family Support Coordinator to join the Family Support Service

  • Judes birthday fundraiser

    Judes birthday fundraiser

    To help Jude get to America to get the next step of his treatment ❤️

  • Rother Valley Sponsored Walk #ForJude

    Rother Valley Sponsored Walk #ForJude

    We are doing a sponsored walk to raise money to get Jude to America for additional cancer treatment

Related

  • Treatment For Neuroblastoma

    Treatment for neuroblastoma varies greatly depending on a child's circumstances. Here you can read about common therapies used for high-risk neuroblastoma in the UK.

  • Diagnosis

    Learn more about what to expect if you suspect your child has neuroblastoma.

  • Risk Groups and Staging

    Neuroblastoma is diagnosed with an associated stage and risk group. Learn more about each one and what it means.

  • What is Neuroblastoma?

    Neuroblastoma is a rare and aggressive childhood cancer that affects around 100 children each year in the UK. It has one of the lowest survival rates.

  • Neuroblastoma Symptoms

    Know the signs and symptoms of neuroblastoma.

Most read

  • Beau's Campaign

    Beau's Campaign

    Beau was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in December 2020. Her family are appealing for your help to raise £317,000 by May 2022.

  • Flora's Campaign

    Flora's Campaign

    In January 2021 Flora was diagnosed with Autism Spectrum Disorder, and just three months later her parents were given the devastating news she had high-risk neuroblastoma. Her family are appealing for your help to raise £312,000 by August 2022 for Flora to enrol on the Bivalent Vaccine clinical trial in New York that aims to stop her neuroblastoma from coming back.

  • Joseph Yeandle

    Joseph Yeandle

    We are devastated to share the news that beautiful Joseph has sadly passed away.

  • Jude's Campaign

    Jude's Campaign

    Jude is a Dinosaur and animal-loving three-year-old. In July 2021 Jude was diagnosed with high-risk neuroblastoma, a rare and aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.

  • Maysaa's Campaign

    Maysaa's Campaign

    Four-year-old Maysaa was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in March 2021. Her family are asking for your support to raise £106,000 by August 2022 for Maysaa to enrol on the DFMO study in Charlotte that aims to stop her neuroblastoma from coming back.

  • Chloe’s Journey

    Chloe’s Journey

    Beautiful Chloe passed away on the 4th of February 2022.

  • Eden's Campaign

    Eden's Campaign

    Six-year-old Eden was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in April 2021.

  • Peter's Campaign

    Peter's Campaign

    11-year-old Peter was diagnosed with neuroblastoma in early 2019. Devastatingly he relapsed in August 2020 after being clear of disease for 6 months. His family are asking for your support to raise £152,000 so that Peter can complete the DFMO study in Charlotte, North Carolina.

  • Kayla's Campaign

    Kayla's Campaign

    Three-year-old Kayla was diagnosed with high-risk neuroblastoma in May 2021. Kayla’s parents are asking for your help to raise £221,000 by November 2022 for Kayla to enrol on the bivalent vaccine clinical trial in New York that aims to stop her neuroblastoma from coming back.

  • Ollie Sweeney

    Ollie Sweeney

    Ollie's family shared the devastating news that their beautiful boy passed away on Sunday 18th July 2021.

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

Contact us

Solving Kids' Cancer UK
Coram Campus
41 Brunswick Square
London
WC1N 1AZ

Phone: 020 7284 0800

Follow us

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn

  • Jobs
  • Media enquiries
  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Safeguarding Statement
  • Privacy Policy

Solving Kids’ Cancer UK is a registered charity in England and Wales (1135601), and in Scotland (SCO45094). It is a company limited by guarantee in England and Wales (7208648). The charity and company is currently operating as Solving Kids’ Cancer.